Clinical Trials at Centra Alan B Pearson Regional Cancer Center
As of September 2026, 13 paid clinical trials are recruiting at Centra Alan B Pearson Regional Cancer Center in Lynchburg, Virginia. Active studies at this site cover conditions such as Breast Cancer, Geographic Atrophy and Lung Non-Small Cell Carcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at Centra Alan B Pearson Regional Cancer Center
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
E-Mindfulness Approaches for Living After Breast Cancer
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Common conditions studied in Lynchburg
- Breast Cancer (3 active studies)
- Geographic Atrophy (3 active studies)
- Lung Non-Small Cell Carcinoma (3 active studies)
- Macular Degeneration (3 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Crohn's Disease (2 active studies)
Leading research sponsors in Lynchburg
- Alliance for Clinical Trials in Oncology
- Genentech, Inc.
- Janssen Research & Development, LLC
- NRG Oncology
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Lynchburg?
There are approximately 55 recruiting clinical trials in Lynchburg, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lynchburg pay participants?
Most recruiting trials in Lynchburg compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lynchburg?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lynchburg?
The most common conditions under active study in Lynchburg include Breast Cancer (3), Geographic Atrophy (3), Lung Non-Small Cell Carcinoma (3), Macular Degeneration (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lynchburg?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lynchburg on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lynchburg?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lynchburg?
Recruiting research sites in Lynchburg include Centra Alan B Pearson Regional Cancer Center, Piedmont Eye Center, Blue Ridge Medical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lynchburg right now?
The largest active categories in Lynchburg are Eye & vision (16), Cancer & tumors (14), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.